Ads
related to: stocks, drugmakerinvesco.com has been visited by 100K+ users in the past month
Search results
London stocks open nearly 1% higher, eye European rate cut; GSK slumps
Reuters· 5 days agoLondon stocks kicked off the week on a positive note, echoing counterparts in Asia, as investors...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg· 5 days agoGSK Plc shares plunged in the wake of a court ruling that the UKdrugmaker, alongside others...
Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why
Zacks· 4 days agoThis predefined screen makes it really easy to shortlist the stocks that have enough fundamental strength to maintain their recent uptrend. Also, the screen passes only the stocks that are trading ...
Bill Ackman Wants Your Money. Should You Buy Pershing Square USA?
Barrons.com· 22 hours agoHis main current investment vehicle, the London- and Euronext...
Weight-loss drugmaker's stock balloons on oral GLP-1 trial data - San Francisco Business Times
The Business Journals· 5 days agoWall Street less than six months ago nearly halved the stock of oral weight-loss drug company...
2 Dividend Stocks Billionaires Are Buying: Should You? | The Motley Fool
The Motley Fool· 1 day agoMany billionaires are active on Wall Street and largely built their wealth that way. Of course,...
Nvidia Stock, These Other Companies Make Waves As IBD Sector Leaders
Investor's Business Daily· 2 days agoAnalysts call for earnings of 78 cents a share, a gain of 36%, with a 31% sales gain to $140.1...
BridgeBio Stock Gives Up Gains On Comparisons To BioMarin Drug
Investor's Business Daily· 4 days agoBridgeBio reversed premarket gains and tumbled Tuesday after thedrugmaker's growth disorder...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 3 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 3 days agoAbbVie: A top dividend growth stock AbbVie is a powerhouse dividend payer. Apart from its superb yield of 3.87%, the company has also increased the size...
Ad
related to: stocks, drugmaker
